Cargando…
A phase I/II dose-escalation single center study to evaluate the safety of infusion of memory t cells as adoptive therapy in coronavirus pneumonia and /or lymphopenia (release)
Autores principales: | Perez-Martinez, A., Ferreras, C., Mora-Rillo, M., Guerra, P., Pascual-Miguel, B., Mestre-Durán, C., Borobia, A.M., Carcas, A., Quiroga, J., García, I., Sánchez-Zapardiel, E., Gasior, M., de Paz, R., Marcos, A., Vicario, J.L., Balas, A., Eguizabal, C., Solano, C., Arribas, J.R., de Miguel, R., Montejano, R., Soria, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Cell & Gene Therapy. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111904/ http://dx.doi.org/10.1016/S1465324921002905 |
Ejemplares similares
-
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)
por: Pérez-Martínez, A., et al.
Publicado: (2021) -
A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol
por: García-García, I., et al.
Publicado: (2021) -
A Phase I/II Dose-Escalation Multi-Center Study to Evaluate the Safety of Infusion of Natural Killer Cells or Memory T Cells As Adoptive Therapy in Coronavirus Pneumonia and/or Lymphopenia: (RELEASE NCT04578210)
por: Pérez-Martínez, Antonio, et al.
Publicado: (2021) -
Immunotherapy: EVALUATION OF MEMORY T CELLS AS ADOPTIVE THERAPY IN CORONAVIRUS PNEUMONIA AND/OR LYMPHOPENIA: A PHASE II CLINICAL TRIAL (RELEASE NCT04578210)
por: Ferreras, C., et al.
Publicado: (2023) -
A Phase II Randomized Multi-Center Study to Evaluate the Safety and Efficacy of Infusion of Memory T Cells As Adoptive Therapy in Coronavirus Pneumonia and/or Lymphopenia (RELEASE NCT04578210)
por: Perez, Antonio, et al.
Publicado: (2022)